AI assistant
Sending…
AMICUS THERAPEUTICS, INC. — Director's Dealing 2012
Jun 15, 2012
31523_dirs_2012-06-15_63ac3bd3-3529-4f43-af90-a456d7be277b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2012-06-13
Reporting Person: LOVE TED W (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-06-13 | Stock Option (right to buy) | $4.79 | A | 30000 | Acquired | 2022-06-13 | Common Stock (30000) | Direct |
Footnotes
F1: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on June 13, 2013. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on July 1, 2013, with the final installment vesting on June 13, 2016.
More from AMICUS THERAPEUTICS, INC.
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 27
Transaction in Own Shares
2026
Apr 27
Transaction in Own Shares
2026
Apr 27
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 27
Transaction in Own Shares
2026
Apr 27
Regulatory Filings
2026
Apr 27